GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Saniona AB (OSTO:SANION) » Definitions » Deferred Policy Acquisition Costs

Saniona AB (OSTO:SANION) Deferred Policy Acquisition Costs


View and export this data going back to 2014. Start your Free Trial

What is Saniona AB Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Saniona AB (OSTO:SANION) Business Description

Industry
Traded in Other Exchanges
Address
Smedeland 26B, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219.